Science Explorer Back to mapMap
Institution · Kyowa Kirin (France)

Most cited papers from Kyowa Kirin (France)

What are the most cited papers from Kyowa Kirin (France)?

The most cited paper from Kyowa Kirin (France) is "Klotho converts canonical FGF receptor into a specific receptor for FGF23" (Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al., 2006), with 1,855 citations. Next come "A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors" (158) and "Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study" (148).

Showing 50 of 61 papers. Every paper with more than 13 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Klotho converts canonical FGF receptor into a specific receptor for FGF23 Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al. · Nature 29 Oct 2006 1,855
2 A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors Toshihiko Doi, Kei Muro, Hiroshi Ishii et al. · Clinical Cancer Research 27 Aug 2019 158
3 Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study Hidemi Nakagawa, Hiroaki Niiro, Kenji Ootaki · Journal of Dermatological Science 26 Oct 2015 148
4 Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study Dmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor et al. · Clinical Cancer Research Open access 25 Jun 2020 64
5 The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse model Hiroaki Ohno, Yasunori Uemura, Hideko Murooka et al. · European Journal of Immunology Open access 17 Dec 2007 64
6 Multi–cell type gene coexpression network analysis reveals coordinated interferon response and cross–cell type correlations in systemic lupus erythematosus Bharat Panwar, Benjamin Joachim Schmiedel, Shu Ying Liang et al. · Genome Research Open access 5 Mar 2021 60
7 TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling Rana Herro, Haruka Miki, Gurupreet Singh Sethi et al. · The Journal of Immunology Open access 21 Sep 2020 55
8 A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma Jamie D. Cavenagh, Heather E. Oakervee, P Baetiong-Caguioa et al. · British Journal of Cancer Open access 5 Sep 2017 54
9 Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS Hirotaka Komaba, Junhui Zhao, Suguru Yamamoto et al. · Journal of Cachexia Sarcopenia and Muscle Open access Jun 2021 50
10 How do adenosine A2A receptors regulate motor function? Akihisa Mori · Parkinsonism & Related Disorders Open access Nov 2020 50
11 Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real‐world French study Marie Beylot-Barry, Gaelle Quereux, Charlée Nardin et al. · Journal of the European Academy of Dermatology and Venereology Open access 28 Apr 2023 49
12 Cytokine induction by a linear 1,3-glucan, curdlan-oligo, in mouse leukocytes in vitro Toshie H. Hida, Kenichi Ishibashi, Noriko N. Miura et al. · Inflammation Research 2009 45
13 Evaluation of glycosylation for quality assurance of antibody pharmaceuticals by capillary electrophoresis Satoru Kamoda, Kazuaki Kakehi · Electrophoresis Aug 2008 44
14 Search for new lead compounds: The example of the chemical and pharmacological dissection of aminopyridazines Camille‐Georges Wermuth · Journal of Heterocyclic Chemistry Sep 1998 43
15 Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors David S. Hong, Olivier Rixe, Vi K. Chiu et al. · Clinical Cancer Research Open access 9 Nov 2021 42
16 Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism Tadao Akizawa, Kazuaki Ikejiri, Yuichiro Kondo et al. · Therapeutic Apheresis and Dialysis Open access 5 Sep 2019 39
17 Crossbreeding of a metallic color carnation and diversification of the peculiar coloration by ion-beam irradiation Masachika Okamura, Masayoshi Nakayama, Naoyuki Umemoto et al. · Euphytica Open access 17 Jan 2013 38
18 Modernizing Preclinical Drug Development: The Role of New Approach Methodologies Krina Mehta, Christian Alexander Maass, L. Cucurull-Sanchez et al. · ACS Pharmacology & Translational Science Open access 29 May 2025 37
19 The discovery of a new antibody for BRIL-fused GPCR structure determination Hikaru Miyagi, Hidetsugu Asada, Michihiko Suzuki et al. · Scientific Reports Open access 15 Jul 2020 34
20 Anti‐tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model Eri Taguchi, Kazuhide Nakamura, Toru Miura et al. · Cancer Science Open access 15 Jan 2008 34
21 Mode of Action of Adenosine A2A Receptor Antagonists as Symptomatic Treatment for Parkinson's Disease Akihisa Mori · International review of neurobiology Book chapter 2014 32
22 Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis Dai Ishikawa, Xiaochen Zhang, Kei Nomura et al. · Inflammatory Bowel Diseases 4 Apr 2024 31
23 The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis Yasunori Uemura, Hiroaki Ohno, Yumiko Ohzeki et al. · Journal of Neuroimmunology Mar 2008 31
24 The electronic and magnetic properties of Fe3N Samir F. Matar, B. Siberchicot, Michel Pénicaud et al. · Journal de Physique I Open access Sep 1992 29
25 Domain Decomposition Methods for Partial Differential Equations On Parallel Computers Gérard Meurant · The International Journal of High Performance Computing Applications Dec 1988 28
26 Magnetic order and chemical bonding in the high- TC molecule-based cyanide magnets CsM[Cr(CN)6] ( M=Mn, Ni) from first principles Volker Eyert, B. Siberchicot, Michel Verdaguer · Physical review. B, Condensed matter Oct 1997 28
27 Clinical observation of 14 cases of childhood polyarteritis nodosa in Japan MOTOHARU MAEDA, MUNEMITSU KOBAYASHI, SHIZUKA OKAMOTO et al. · Pediatrics International Apr 1997 27
28 Ermüdungsbemessungsmodell für normal‐, hoch‐ und ultrahochfeste Betone Ludger Lohaus, Maik Wefer, Nadja Oneschkow · Beton- und Stahlbetonbau Dec 2011 26
29 Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates Aihua Song, Kensuke Myojo, John Laudenslager et al. · Antiviral Research 16 Sep 2014 26
30 Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia Takashi Shigematsu, Yotaro Une, Kazuaki Ikejiri et al. · American Journal of Nephrology Open access 2021 25
31 TCP: a tool for designing chimera proteins based on the tertiary structure information Takashi Yoneya, Reina Nishida · BMC Bioinformatics Open access 7 Jan 2009 25
32 Genetic mechanism regulating bacterial cell shape and metabolism Daisuke Shiomi, Hideo Mori, Hironori Niki · Communicative & Integrative Biology Open access May 2009 25
33 The Life Cycle and Management of Protocol Deviations Munish Mehra, Katharina Kurpanek, Maryrose Petrizzo et al. · Therapeutic Innovation & Regulatory Science 18 Apr 2014 25
34 Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study Seong Jun Seo, Bong Seok Shin, Joo‐Heung Lee et al. · The Journal of Dermatology Open access 29 Dec 2020 24
35 A novel screening test to predict the developmental toxicity of drugs using human induced pluripotent stem cells Nobuo Aikawa · The Journal of Toxicological Sciences Open access 2020 24
36 Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome Marie Beylot-Barry, Nina Booken, Carsten Weishaupt et al. · Journal of the European Academy of Dermatology and Venereology Open access 22 Aug 2022 21
37 Analytical Method Validation for Biomarkers As a Drug Development Tool: Points to Consider Yoshiaki Ohtsu, Seiji Tanaka, Harue Igarashi et al. · Bioanalysis Sep 2021 21
38 Can adenosine A2A receptor antagonists modify motor behavior and dyskinesia in experimental models of Parkinson's disease? Tomoyuki Kanda, Peter G. Jenner · Parkinsonism & Related Disorders Open access Nov 2020 21
39 Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment-Related Adverse Events From the CheckMate 040 Study Karen Julien, Hiu Tung Leung, Carmen Fuertes et al. · The Oncologist Open access 23 Jul 2020 21
40 Preclinical and first‐in‐human phase I studies of KW ‐2450, an oral tyrosine kinase inhibitor with insulin‐like growth factor receptor‐1/insulin receptor selectivity Gary K. Schwartz, Mark Andrew Dickson, Patricia Mucci LoRusso et al. · Cancer Science Open access 6 Feb 2016 21
41 Improving impurities clearance by amino acids addition to buffer solutions for chromatographic purifications of monoclonal antibodies Takashi Ishihara, Mareto Hosono · Journal of Chromatography B 18 May 2015 21
42 Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation Antoine Lemaire, Y. Pointreau, Bérengère Narciso et al. · Supportive Care in Cancer Open access 13 Jun 2021 20
43 Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study Ma. Dolores López Alarcón, Francisco Villegas Estévez, Luis Cabezón‐Gutiérrez et al. · Journal of Geriatric Oncology 26 Apr 2019 20
44 Calculated magnetic and electronic properties of the double perovskites La2TIrO6 (T=Mn, Fe, Co) Michael K. Uhl, Samir F. Matar, B. Siberchicot · Journal of Magnetism and Magnetic Materials Aug 1998 20
45 Look-Up Tables for Medial Axis on Squared Euclidean Distance Transform Éric Rémy, Édouard Thiel · Lecture notes in computer science Conference paperOpen access 2003 20
46 Innovative next-generation monoclonal antibody purification using activated carbon: A challenge for flow-through and column-free processes Takashi Ishihara, Maki Miyahara, Tsuyoshi Yamada et al. · Journal of Chromatography B 10 May 2019 19
47 Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia Tomoyuki Kanda, Shinichi Uchida · International review of neurobiology Book chapter 2014 18
48 The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution Beverly A. Teicher, Hans-Peter Biemann, George Vande Woude et al. · International Journal of Oncology Open access Apr 2008 18
49 ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis Emma Guttman‐Yassky, Eric Lawrence Simpson, Robert Bissonnette et al. · Immunotherapy Open access 22 Jan 2025 17
50 Efficient production of lacto-N-fucopentaose III in engineered Escherichia coli using α1,3-fucosyltransferase from Parabacteroides goldsteinii Tomotoshi Sugita, Sotaro Sampei, Kento Koketsu · Journal of Biotechnology 9 Dec 2022 17

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.